EirGenix, Inc.
Peter Lee, MBA, MS, currently serves as the Vice President of Business Development at EirGenix, Inc., where expertise in biologics and global manufacturing capabilities is leveraged. Previously, Peter held leadership positions at Abzena and Olon Ricerca Bioscience, contributing to business development strategies within the biopharmaceutical sector. A background in project management at Samsung Biologics involved enhancing internal communication processes and fostering employee growth, while earlier roles at AbbVie and Abbott focused on account management and consultancy. Peter holds an MBA from The Johns Hopkins University and an MS in Clinical Microbiology from the Medical College of Virginia.
This person is not in any offices
EirGenix, Inc.
2 followers
EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars. Our Services: - Cell Line Development (mammalian/microbial systems) - Process Development and Process Optimization - Analytical Services and Quality Control - cGMP Manufacturing (mammalian/microbial systems) - Taiwan FDA inspected/approved - Japan PMDA inspected/approved - U.S. FDA inspection pending (June 2022) - EMA inspection pending (2022-2023) - Antibody-Drug Conjugate (ADC) Development and Manufacturing